{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:51:10Z","timestamp":1790819470798,"version":"4.1.0"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1586\/14737140.4.1.27","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T13:05:28Z","timestamp":1105621528000},"page":"27-36","source":"Crossref","is-referenced-by-count":33,"title":["Pentostatin (Nipent\u00ae) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia"],"prefix":"10.1586","volume":"4","author":[{"given":"Robert O","family":"Dillman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-0734.2002.00304.x"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-0734.2002.00305.x","volume":"6","author":"Tallman MS","year":"2002","journal-title":"Rev. Clin. Exp. Hematol"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1182\/blood.V92.6.1918","volume":"92","author":"Saven A","year":"1998","journal-title":"Blood"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1468-0734.2002.00303.x","volume":"6","author":"Keating MJ","year":"2002","journal-title":"Rev Clin. Exp. Hematol"},{"key":"CIT0006","first-page":"1165","volume":"92","author":"Keating MJ","year":"1998","journal-title":"B\/ooc\/"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJM200012143432402","volume":"343","author":"Rai KR","year":"2000","journal-title":"N. Engl. Med"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.1992.10.3.352","volume":"10","author":"Cheson BD","year":"1992","journal-title":"j Clin. Oncol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/1099-1069(200012)18:4<141::AID-HON666>3.0.CO;2-#","volume":"18","author":"Johnson SA","year":"2000","journal-title":"Hematol Oncol"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V86.7.2463.2463","volume":"86","author":"Tallman MS","year":"1995","journal-title":"Blood"},{"key":"CIT0015","first-page":"91","volume":"58","author":"Major PP","year":"1981","journal-title":"Clinical pharmacology of deoxycoformycin. Blood"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000421-198204000-00066","volume":"5","author":"Kanofsky JR","year":"1982","journal-title":"A pilot study. Am. Clin. Oncol"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/JCO.1985.3.9.1196","volume":"3","author":"Greyer MR","year":"1985","journal-title":"J Clin. Oncol"},{"key":"CIT0020","first-page":"297","volume":"68","author":"Foon KA","year":"1986","journal-title":"Response to deoxycoformycin after failure of interferon-a in nonsplenectomized patients with hairy cell leukemia. Blood"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/BF01717832","volume":"65","author":"Ho AD","year":"1987","journal-title":"Wochenschr"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2141.1986.tb07530.x","volume":"63","author":"Johnston JB","year":"1986","journal-title":"BE j Haematol"},{"key":"CIT0023","first-page":"1119","volume":"68","author":"Kraut EH","year":"1986","journal-title":"Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Blood"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.1991.9.2.243","volume":"9","author":"Cassileth PA","year":"1991","journal-title":"j Clin. Oncol"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/80.10.765","volume":"80","author":"Johnston JB","year":"1988","journal-title":"j Natl Cancer Inst"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.2830330309","volume":"33","author":"Blick M","year":"1990","journal-title":"Aim I Hematol"},{"key":"CIT0030","first-page":"1533","volume":"7","author":"Ho AD","year":"1989","journal-title":"The European Organization for Research and Treatment of Cancer Leukemia Co-operative Group. j Clin. Oncol"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.1990.8.4.721","volume":"8","author":"Martin A","year":"1990","journal-title":"j Clin. Oncol"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<65::AID-CNCR9>3.0.CO;2-B","volume":"85","author":"Ribeiro P","year":"1999","journal-title":"Cancer"},{"key":"CIT0037","first-page":"515","volume":"106","author":"Dearden CE","year":"1999","journal-title":"Long-term follow-up of patients with hairy cell leukemia after treatment with pentostatin or cladribine. BE II-Lematol"},{"key":"CIT0039","first-page":"9","volume":"27","author":"Margolis J","year":"2000","journal-title":"Semin. Oncol"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V57.3.406.406","volume":"57","author":"Greyer MR","year":"1981","journal-title":"Blood"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/jnci\/82.17.1416","volume":"82","author":"Ho AD","year":"1990","journal-title":"j Natl Cancer Inst"},{"key":"CIT0047","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.leu.2401892","volume":"14","author":"Weiss MA","year":"2000","journal-title":"Leukemia"},{"key":"CIT0048","first-page":"71","volume":"96","author":"Flinn IW","year":"2000","journal-title":"B\/ooc\/"},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1200\/JCO.2001.19.5.1414","volume":"19","author":"O'Brien SM","year":"2001","journal-title":"j Clin. Oncol"},{"key":"CIT0051","first-page":"235","volume":"103","author":"Ketterer N","year":"1998","journal-title":"BE II-Lematol"},{"key":"CIT0057","first-page":"114","volume":"97","author":"Montillo M","year":"2003","journal-title":"Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocyte leukemia and prolymphocytic leukemia. Cancer"},{"key":"CIT0058","first-page":"16","volume":"31","author":"Dillman RO","year":"1994","journal-title":"Semin. Hematol"},{"key":"CIT0059","first-page":"848","volume":"8","author":"Kraut EH","year":"1990","journal-title":"Immunosuppressive effects of pentostatin. Clin. Oncol"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1200\/JCO.1999.17.8.2454","volume":"17","author":"Cheson BD","year":"1999","journal-title":"J. Clin. Oncol"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737140.4.1.27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T09:10:32Z","timestamp":1586077832000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737140.4.1.27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1586\/14737140.4.1.27"],"URL":"https:\/\/doi.org\/10.1586\/14737140.4.1.27","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}